Specialty distributor skillset quantified

New research shows that specialty drug distributors save the healthcare industry $3.5 billion compared with the cost projected when manufacturers and healthcare providers do the job. The savings reach $8 billion when researchers factor in traditional drug distributors that handle the cancer, biotech and other drugs requiring low-tolerance, in-transit conditions.

High-tech, cold-chain and just-in-time delivery skills separate specialty distributors from other drug handlers, says the Center for Healthcare Supply Chain Research, a foundation of the Healthcare Distribution Management Association. Consultant Arthur D. Little conducted the study.

Techniques for preserving delicate medicines and an array of value-added services further separate the specialists from traditional drug handlers.

Big-name distributors appear to be aware of the chink in their armor. Both AmerisourceBergen and Cardinal have proclaimed recently a specialty drug distribution objective, as reported Tuesday.

- see the release

Special Report: The Big 3 Distributors


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.